Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging.

[1]  Hisataka Kobayashi,et al.  Nano-sized MRI contrast agents with dendrimer cores. , 2005, Advanced drug delivery reviews.

[2]  M. Oka,et al.  Lymphatic drainage from esophagogastric tract: feasibility of endoscopic CT lymphography for direct visualization of pathways. , 2005, Radiology.

[3]  Comparison of Gd [DTPA‐bis (2‐aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: Experimental study with rabbits , 2005, Journal of magnetic resonance imaging : JMRI.

[4]  Hidetoshi Arima,et al.  Improvement of gene delivery mediated by mannosylated dendrimer/α-cyclodextrin conjugates , 2005 .

[5]  T. Tsuji,et al.  Interstitial Magnetic Resonance Lymphography Using Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid in Rabbits With Lymph Node Metastasis , 2005, Investigative radiology.

[6]  Hisataka Kobayashi,et al.  Dendrimer-based nanosized MRI contrast agents. , 2004, Current pharmaceutical biotechnology.

[7]  H. Weinmann,et al.  Early MR lymphography with gadofluorine M in rabbits. , 2004, Radiology.

[8]  Hisataka Kobayashi,et al.  Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. , 2004, Journal of the National Cancer Institute.

[9]  M. Brechbiel,et al.  Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  M. Oka,et al.  Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience. , 2004, Radiology.

[11]  M. Sasa,et al.  3-Dimensional Computed Tomography Lymphography–Guided Identification of Sentinel Lymph Nodes in Breast Cancer Patients Using Subcutaneous Injection of Nonionic Contrast Medium: A Clinical Trial , 2004, Journal of computer assisted tomography.

[12]  J. Bresnahan,et al.  Boron Neutron Capture Therapy of Brain Tumors: Functional and Neuropathologic Effects of Blood–Brain Barrier Disruption and Intracarotid Injection of Sodium Borocaptate and Boronophenylalanine , 2000, Journal of Neuro-Oncology.

[13]  A. Urtti,et al.  Extracellular and intracellular barriers in non-viral gene delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Michael V Knopp,et al.  Comparison of dendrimer‐based macromolecular contrast agents for dynamic micro‐magnetic resonance lymphangiography , 2003, Magnetic resonance in medicine.

[15]  J. Debatin,et al.  Assessment of normal, inflammatory, and tumor‐bearing lymph nodes with contrast‐enhanced interstitial magnetic resonance lymphography: Preliminary results in rabbits , 2003, Journal of magnetic resonance imaging : JMRI.

[16]  S. Leong.  Selective sentinel lymphadenectomy for malignant melanoma. , 2003, The Surgical clinics of North America.

[17]  Hisataka Kobayashi,et al.  Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. , 2003, Cancer research.

[18]  Martin W. Brechbiel,et al.  Dendrimer-based macromolecular MRI contrast agents: characteristics and application. , 2003 .

[19]  Francis C Szoka,et al.  Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. , 2002, Bioconjugate chemistry.

[20]  E. Morita.  Lymphoscintigraphy in the detection of sentinel lymph nodes. , 2002, Cancer treatment and research.

[21]  M. Brechbiel,et al.  Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores , 2001, Magnetic resonance in medicine.

[22]  K Togashi,et al.  Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  Akira Hiraga,et al.  Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core , 2001, Magnetic resonance in medicine.

[24]  R. Gelber,et al.  Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Aarsvold,et al.  Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma detecting probe. , 2001, Radiologic clinics of North America.

[26]  M. Brechbiel,et al.  Novel intravascular macromolecular MRI contrast agent with generation‐4 polyamidoamine dendrimer core: Accelerated renal excretion with coinjection of lysine , 2001, Magnetic resonance in medicine.

[27]  M. Brechbiel,et al.  Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. , 2001, Bioconjugate chemistry.

[28]  M. Brechbiel,et al.  3D‐micro‐MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties , 2001, Magnetic resonance in medicine.

[29]  G. Viale,et al.  Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. , 2001, European journal of cancer.

[30]  M. Pfreundschuh,et al.  Tumour vaccines: a new immunotherapeutic approach in oncology , 2000, Annals of Hematology.

[31]  K. Kono,et al.  Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.

[32]  Y. Sakurai,et al.  Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. , 2000, Cancer letters.

[33]  Y. Akine,et al.  Comparison of Radiation Effects of Gadolinium and Boron Neutron Capture Reactions , 2000, Strahlentherapie und Onkologie.

[34]  D. Reintgen,et al.  The role of sentinel lymph node biopsy in breast cancer. , 1999, Journal of the American College of Surgeons.

[35]  R. Zhuo,et al.  In vitro release of 5-fluorouracil with cyclic core dendritic polymer. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[36]  W. Semmler,et al.  Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol. , 1999, Investigative radiology.

[37]  M. Hawthorne.  New horizons for therapy based on the boron neutron capture reaction. , 1998, Molecular medicine today.

[38]  R. Gelber,et al.  Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. , 1995, Journal of the National Cancer Institute.

[39]  M. Fan,et al.  Lymph node micrometastases from breast carcinoma , 1997, Cancer.

[40]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  T. Waldmann,et al.  Identification of a novel receptor/signal transduction pathway for IL‐15/T in mast cells , 1996, The EMBO journal.

[42]  R. Barth,et al.  Boron neutron capture therapy of brain tumors: past history, current status, and future potential. , 1996, Cancer investigation.

[43]  R. Gelber,et al.  Meeting highlights: international consensus panel on the treatment of primary breast cancer. , 2002, Journal of the National Cancer Institute.

[44]  R. Lawaczeck,et al.  Neutron capture therapy with gadopentetate dimeglumine: experiments on tumor-bearing rats. , 1995, Academic radiology.

[45]  P C Lauterbur,et al.  Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.

[46]  B. Myers,et al.  Selectivity of the glomerular filtration barrier in healthy and nephrotic humans. , 1993, American journal of nephrology.

[47]  Y. Akine,et al.  Suppression of Rabbit VX‐2 Subcutaneous Tumor Growth by Gadolinium Neutron Capture Therapy , 1993, Japanese journal of cancer research : Gann.

[48]  Y. Akine,et al.  Electron-equivalent dose for the effect of gadolinium neutron capture therapy on the growth of subcutaneously-inoculated Ehrlich tumor cells in mice. , 1993, Japanese journal of clinical oncology.

[49]  W. Sauerwein.  Principles and history of neutron capture therapy. , 1993, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[50]  T. Matsumoto.  Transport calculations of depth-dose distributions for gadolinium neutron capture therapy. , 1992, Physics in medicine and biology.

[51]  R. Barth,et al.  Boron neutron capture therapy of cancer. , 1990, Cancer research.

[52]  R. Barth,et al.  Tumor targeting agents for neutron capture therapy. , 1990, Basic life sciences.

[53]  B. Allen.  Neutron capture therapy research in Australia. , 1989, Pigment cell research.

[54]  B. Allen,et al.  Induction of DNA double-strand breaks by 157Gd neutron capture. , 1989, Pigment cell research.

[55]  Brugger Rm,et al.  Evaluation of gadolinium-157 as a neutron capture therapy agent. , 1989 .

[56]  B. Allen,et al.  Induction of double-strand breaks following neutron capture by DNA-bound 157Gd. , 1988, International journal of radiation biology.

[57]  L. Hunsicker,et al.  Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats. , 1985, Kidney international.

[58]  C. Redmond,et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.

[59]  H. Rennke,et al.  Glomerular filtration of proteins: clearance of anionic, neutral, and cationic horseradish peroxidase in the rat. , 1978, Kidney international.